Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Votre FBAUC : Préserver l’héritage de la recherche canadienne en urologie.

Curtis Nickel J, Izawa JI, Pace KT.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E60-E61. doi: 10.5489/cuaj.4446. Epub 2017 Feb 20. French. No abstract available.

PMID:
28443151
Free PMC Article
2.

Your CUASF: Keeping Canada's urological research legacy alive.

Curtis Nickel J, Izawa JI, Pace KT.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):71-72. doi: 10.5489/cuaj.4423. No abstract available.

3.

The Impact of Multiple Prostate Biopsies on Risk for Major Complications Following Radical Prostatectomy: A Population-based Cohort Study.

Olvera-Posada D, Welk B, McClure JA, Winick-Ng J, Izawa JI, Pautler SE.

Urology. 2017 Aug;106:125-132. doi: 10.1016/j.urology.2017.03.048. Epub 2017 Apr 21.

PMID:
28438629
4.

Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation.

Cool DW, Romagnoli C, Izawa JI, Chin J, Gardi L, Tessier D, Mercado A, Mandel J, Ward AD, Fenster A.

Can Urol Assoc J. 2016 Sep-Oct;10(9-10):342-348.

5.

Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.

Biggs CN, Siddiqui KM, Al-Zahrani AA, Pardhan S, Brett SI, Guo QQ, Yang J, Wolf P, Power NE, Durfee PN, MacMillan CD, Townson JL, Brinker JC, Fleshner NE, Izawa JI, Chambers AF, Chin JL, Leong HS.

Oncotarget. 2016 Feb 23;7(8):8839-49. doi: 10.18632/oncotarget.6983.

6.

CUA guidelines on the management of non-muscle invasive bladder cancer.

Kassouf W, Traboulsi SL, Kulkarni GS, Breau RH, Zlotta A, Fairey A, So A, Lacombe L, Rendon R, Aprikian AG, Siemens DR, Izawa JI, Black P.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E690-704. doi: 10.5489/cuaj.3320. Epub 2015 Oct 13. No abstract available.

7.

Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.

Siddiqui KM, Izawa JI.

World J Urol. 2016 Jan;34(1):19-24. doi: 10.1007/s00345-015-1706-1. Epub 2015 Oct 16. Review.

PMID:
26475274
8.

Systematic methods for measuring outcomes: How they may be used to improve outcomes after Radical cystectomy.

Siddiqui KM, Izawa JI.

Arab J Urol. 2015 Jun;13(2):122-7. doi: 10.1016/j.aju.2015.02.008. Epub 2015 Mar 29. Review.

9.

Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9].

Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF.

Eur Urol. 2015 Jul;68(1):171. doi: 10.1016/j.eururo.2015.02.007. Epub 2015 Feb 18. No abstract available.

PMID:
26088736
10.

Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.

Cool DW, Zhang X, Romagnoli C, Izawa JI, Romano WM, Fenster A.

AJR Am J Roentgenol. 2015 Jan;204(1):83-91. doi: 10.2214/AJR.14.12681.

PMID:
25539241
11.

The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.

Lucca I, Kassouf W, Kapoor A, Fairey A, Rendon RA, Izawa JI, Black PC, Fajkovic H, Seitz C, Remzi M, Nyirády P, Rouprêt M, Margulis V, Lotan Y, de Martino M, Hofbauer SL, Karakiewicz PI, Briganti A, Novara G, Shariat SF, Klatte T.

BJU Int. 2015 Jul;116(1):72-8. doi: 10.1111/bju.12801. Epub 2015 Mar 6.

12.

Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.

Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Wei C, Lerner SP, Curiel TJ, Kamat AM, Svatek RS.

Urology. 2014 Apr;83(4):863-7. doi: 10.1016/j.urology.2013.10.060. Epub 2014 Jan 31.

PMID:
24485993
13.

Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration.

Bachir BG, Aprikian AG, Izawa JI, Chin JL, Fradet Y, Fairey A, Estey E, Jacobsen N, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Kapoor A, Matsumoto E, Saad F, Bell D, Black PC, So AI, Drachenberg D, Kassouf W.

Urol Oncol. 2014 May;32(4):441-8. doi: 10.1016/j.urolonc.2013.10.016. Epub 2014 Jan 10.

PMID:
24412632
14.

Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.

Wang Y, Lang MR, Pin CL, Izawa JI.

Springerplus. 2013 Aug 28;2:412. doi: 10.1186/2193-1801-2-412. eCollection 2013.

15.

Perineural invasion and TRUS findings are complementary in predicting prostate cancer biology.

Martinez CH, Williams AK, Chin JL, Stitt L, Izawa JI.

Can J Urol. 2013 Apr;20(2):6696-701.

PMID:
23587509
16.

Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.

Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A, Kapoor A, Black P, Lacombe L, Tanguay S, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Izawa JI.

Urol Oncol. 2013 Oct;31(7):1161-5. doi: 10.1016/j.urolonc.2011.12.004. Epub 2013 Feb 13.

PMID:
23415596
17.
18.

Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.

Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF.

BJU Int. 2013 Feb;111(2):249-55. doi: 10.1111/j.1464-410X.2012.11322.x. Epub 2012 Jun 21.

19.

Vertebral osteomyelitis following transrectal ultrasound-guided biopsy of the prostate.

Rajgopal R, Wang Y, Faber KJ, Izawa JI.

Can Urol Assoc J. 2012 Feb;6(1):E20-2. doi: 10.5489/cuaj.11025.

20.

Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M.

Eur Urol. 2012 Feb;61(2):237-42. doi: 10.1016/j.eururo.2011.10.011. Epub 2011 Oct 21.

PMID:
22033174

Supplemental Content

Loading ...
Support Center